Literature DB >> 20199361

Denial of smoking-related risk among pregnant smokers.

Ildikó Tombor1, Róbert Urbán1,2, Tímea Berkes1,2, Zsolt Demetrovics3.   

Abstract

OBJECTIVE: To examine pregnant women's denial of risk, tobacco dependence and their partner's smoking status on smoking behavior during pregnancy.
DESIGN: Cross-sectional design with convenience sampling.
SETTING: Data collection was carried out in hospitals and antenatal clinics in Budapest and 12 other Hungarian cities. POPULATION OR SAMPLE: A total of 406 adult pregnant women (mean age: 28.2 years; SD = 5.6) with a mean gestational age of 23.3 weeks ranging from 4 to 40 (SD = 8.9).
METHODS: Pregnant women were enrolled in the study by midwives and home-care attendants. MAIN OUTCOME MEASURES: Smoking status was assessed by self-report questions. Further measures included the Fagerstrom Test of Nicotine Dependence to assess nicotine dependence, and the Wisconsin Inventory of Smoking Dependence Motives to assess the motivational background of smoking. Risk perception was assessed by Haslam and Draper's (2000) 12-item risk perception questionnaire.
RESULTS: Prevalence of occasional and daily smokers was 21.7 and 29.3%, respectively. Some 59.7% of the pregnant women have a partner who smokes. Daily smokers had a higher level of risk denial than occasional or non-smokers (Welch F = 91.607; p < 0.001). Current smokers also had a higher denial than temporary quitters (t = -3.153; p = 0.003). Denial of risk correlated significantly with nicotine dependence (r = 0.30) and the main motivational factors (r = 0.34-0.48). A multinomial logistic regression model of denial of risk concurrently predicted women's smoking status (p = 0.001), even when controlling for age, education, partner's smoking status and parity.
CONCLUSIONS: A higher level of risk denial seems to be one of the major determinants of women's smoking status during pregnancy.

Entities:  

Mesh:

Year:  2010        PMID: 20199361     DOI: 10.3109/00016341003678427

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Factors associated with quit attempts and quitting among Eastern Hungarian women who smoked at the time of pregnancy.

Authors:  Kristie L Foley; Péter Balázs; Andrea Grenczer; Ildikó Rákóczi
Journal:  Cent Eur J Public Health       Date:  2011-06       Impact factor: 1.163

Review 2.  Epidemiology of substance use in reproductive-age women.

Authors:  R Kathryn McHugh; Sara Wigderson; Shelly F Greenfield
Journal:  Obstet Gynecol Clin North Am       Date:  2014-06       Impact factor: 2.844

3.  Neighborhood safety as a correlate of tobacco use in a sample of urban, pregnant women.

Authors:  Freda Patterson; Laura Seravalli; Alexandra Hanlon; Deborah B Nelson
Journal:  Addict Behav       Date:  2012-05-26       Impact factor: 3.913

4.  Psychometric properties and construct validity of the brief Wisconsin inventory of smoking dependence motives in an Internet-based sample of treatment-seeking Hungarian smokers.

Authors:  Péter Vajer; Róbert Urbán; Ildikó Tombor; Adrienne Stauder; László Kalabay
Journal:  Nicotine Tob Res       Date:  2011-01-24       Impact factor: 4.244

5.  Examination of the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68) Factor Structure in a Sample of Pregnant Smokers.

Authors:  Charlotte E Parrott; Nuvan Rathnayaka; Janice A Blalock; Jennifer A Minnix; Paul M Cinciripini; John P Vincent; David W Wetter; Charles Green
Journal:  Nicotine Tob Res       Date:  2014-12-04       Impact factor: 4.244

6.  Barriers to Smoking Cessation and Characteristics of Pregnant Smokers in Greece.

Authors:  Athina Diamanti; Aikaterini Galiatsatou; Antigoni Sarantaki; Paraskevi Katsaounou; Dimitra Varnakioti; Aikaterini Lykeridou
Journal:  Maedica (Bucur)       Date:  2021-09

7.  A qualitative analysis of messages to promote smoking cessation among pregnant women.

Authors:  Janet Hoek; Heather Gifford; Ninya Maubach; Rhiannon Newcombe
Journal:  BMJ Open       Date:  2014-11-27       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.